MA50489A - SELECTION AND USE OF BACTERIA TO PROMOTE MELATONIN PRODUCTION TO REDUCE CHILD COLIC - Google Patents

SELECTION AND USE OF BACTERIA TO PROMOTE MELATONIN PRODUCTION TO REDUCE CHILD COLIC

Info

Publication number
MA50489A
MA50489A MA050489A MA50489A MA50489A MA 50489 A MA50489 A MA 50489A MA 050489 A MA050489 A MA 050489A MA 50489 A MA50489 A MA 50489A MA 50489 A MA50489 A MA 50489A
Authority
MA
Morocco
Prior art keywords
colic
bacteria
selection
melatonin production
reduce child
Prior art date
Application number
MA050489A
Other languages
French (fr)
Other versions
MA50489B1 (en
Inventor
Bo Möllstam
Stefan Roos
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Priority claimed from PCT/EP2019/069984 external-priority patent/WO2020020982A1/en
Publication of MA50489A publication Critical patent/MA50489A/en
Publication of MA50489B1 publication Critical patent/MA50489B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/165—Heterorings having nitrogen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03031—Nucleotidase (3.1.3.31)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA50489A 2018-07-24 2019-07-24 Selection and use of bacteria promoting melatonin production to reduce infantile colic MA50489B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1812079.0A GB201812079D0 (en) 2018-07-24 2018-07-24 Selection method
PCT/EP2019/069984 WO2020020982A1 (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic

Publications (2)

Publication Number Publication Date
MA50489A true MA50489A (en) 2020-09-02
MA50489B1 MA50489B1 (en) 2022-10-31

Family

ID=63364334

Family Applications (1)

Application Number Title Priority Date Filing Date
MA50489A MA50489B1 (en) 2018-07-24 2019-07-24 Selection and use of bacteria promoting melatonin production to reduce infantile colic

Country Status (3)

Country Link
GB (1) GB201812079D0 (en)
MA (1) MA50489B1 (en)
TW (1) TW202019448A (en)

Also Published As

Publication number Publication date
TW202019448A (en) 2020-06-01
GB201812079D0 (en) 2018-09-05
MA50489B1 (en) 2022-10-31

Similar Documents

Publication Publication Date Title
MA42243A (en) FACTOR XI ANTIBODIES AND METHODS OF USE
DOP2016000114A (en) TREATMENT OF OSTEOARTHRITIS AND PAIN
DK3411400T3 (en) TREATMENT OF INFLAMMATORY DISEASES WITH INHIBITORS OF C5A ACTIVITY
TWD170518S (en) Cosmetic skin treatment apparatus
EA201991484A1 (en) MEDICINAL FORMS OF ENZALUTAMIDE
UY34720A (en) TREATMENT OF MULTIPLE SCLEROSIS WITH A COMBINATION OF LAQUINIMOD AND DIMETILO FUMARATE
DK3372229T3 (en) PROCEDURES TO INCREASE TONIC INHIBITION AND TREATMENT OF ANGELMAN'S SYNDROME
EA201591616A1 (en) TRIFTTOROMETHYL-SUBSTITUTED ANNELATED PYRIMIDINES AND THEIR APPLICATION
MA43811A (en) BICYCLIC ARYLMONOBACTAM COMPOUNDS AND THEIR METHODS OF USE FOR THE TREATMENT OF BACTERIAL INFECTIONS
DK3526207T3 (en) HETEROCYCLIC COMPOUNDS WITH ACTIVITY AS MODULATORS OF MUSCARINE M1 AND / OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAIN
AU201612564S (en) Oral care implement
CO6821932A2 (en) Treatment of pain associated with basal endometrial dislocation
UY34603A (en) ANTI-ASIC-1 ANTIBODIES AND USES OF THE SAME
EA201692284A1 (en) NIACINAMIDE FOR STIMULATING THE PRODUCTION OF ANTIMICROBIAL PEPTIDES
MA48730A (en) COMPOSITIONS AND METHODS OF TREATMENT OF SYNUCLEINOPATHIES
DK3793960T3 (en) Milk of lime
CO2017005732A2 (en) Dihydropyrimidin-2-one Compounds and Their Medical Uses
MA47362A (en) ANTI-TNF ANTIBODIES, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACTIVE PSORIASIC RHEUMATISM
DK3609431T3 (en) DEVICES AND PROCEDURES TO PROMOTE THE PRODUCTION OF FEMALE FEMALE IN EGGS
AU201712739S (en) Oral Care Implement
ZA201903795B (en) Treatment of water
EA201891611A1 (en) DERIVATIVES 3 - ((HETERO-) Aryl) -8-AMINO-2-OXO-1,3-DIAZASPIRO [4,5] DEAN
ITUB20152961A1 (en) ISOLATION AND PURIFICATION OF 6-AMINOCAPROIC ACID
ZA202006891B (en) Selection and use of melatonin supporting bacteria to reduce infantile colic
FR2981265B1 (en) INFLATABLE AND ADJUSTABLE GASTRIC BAND RING FOR THE TREATMENT OF OBESITY